Industry-Sponsored Research are studies driven by pharmaceutical advances, such as a new medication, and usually require long-term enrollment (1-3 years) of a very small group of patients.
Our HTC Industry-Sponsored Trials will vary as to what is available but we have projects ongoing in two main areas: bleeding disorders and clotting disorders.
Much of our research has provided significant results that impact the daily lives of many patients worldwide. Below we will be posting posters and papers that are direct results from research our HTC has been involved in that were industry sponsored trials.